232 related articles for article (PubMed ID: 12460927)
21. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
[TBL] [Abstract][Full Text] [Related]
22. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva.
Hamrah P; Chen L; Cursiefen C; Zhang Q; Joyce NC; Dana MR
Exp Eye Res; 2004 Oct; 79(4):553-61. PubMed ID: 15381039
[TBL] [Abstract][Full Text] [Related]
23. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
Lymboussaki A; Partanen TA; Olofsson B; Thomas-Crusells J; Fletcher CD; de Waal RM; Kaipainen A; Alitalo K
Am J Pathol; 1998 Aug; 153(2):395-403. PubMed ID: 9708800
[TBL] [Abstract][Full Text] [Related]
24. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
Parsons A; Sheehan DJ; Sangueza OP
Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
[TBL] [Abstract][Full Text] [Related]
25. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
26. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
[TBL] [Abstract][Full Text] [Related]
27. Angiogenesis in wound healing and tumor metastasis.
Ruiter DJ; Schlingemann RO; Westphal JR; Denijn M; Rietveld FJ; De Waal RM
Behring Inst Mitt; 1993 Aug; (92):258-72. PubMed ID: 7504453
[TBL] [Abstract][Full Text] [Related]
28. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
[TBL] [Abstract][Full Text] [Related]
29. Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane.
Papoutsi M; Sleeman JP; Wilting J
Microsc Res Tech; 2001 Oct; 55(2):100-7. PubMed ID: 11596155
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic vessel density is significantly increased in melanoma.
Giorgadze TA; Zhang PJ; Pasha T; Coogan PS; Acs G; Elder DE; Xu X
J Cutan Pathol; 2004 Nov; 31(10):672-7. PubMed ID: 15491327
[TBL] [Abstract][Full Text] [Related]
31. The correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor.
Demirkesen C; Büyükpinarbaşili N; Ramazanoğlu R; Oğuz O; Mandel NM; Kaner G
Pathology; 2006 Apr; 38(2):132-7. PubMed ID: 16581653
[TBL] [Abstract][Full Text] [Related]
32. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].
Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D
Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221
[TBL] [Abstract][Full Text] [Related]
33. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
Cohn ML; Goncharuk VN; Diwan AH; Zhang PS; Shen SS; Prieto VG
J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.
Filho AL; Baltazar F; Bedrossian C; Michael C; Schmitt FC
Diagn Cytopathol; 2007 Dec; 35(12):786-91. PubMed ID: 18008346
[TBL] [Abstract][Full Text] [Related]
35. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
Mouawad R; Spano JP; Comperat E; Capron F; Khayat D
Eur J Cancer; 2009 May; 45(8):1407-14. PubMed ID: 19157860
[TBL] [Abstract][Full Text] [Related]
36. Angiogenesis and lymphangiogenesis of skin cancers.
Dadras SS; Detmar M
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1059-70, viii. PubMed ID: 15474335
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K
Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768
[TBL] [Abstract][Full Text] [Related]
39. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
[TBL] [Abstract][Full Text] [Related]
40. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]